| Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|
Cash flows used in operating activities | ||||||
Net loss | ||||||
-11,202 | -12,993 | -13,279 | -13,429 | 0 | 0 | 0 |
Adjustments for: | ||||||
Stock-based compensation | ||||||
- | 0 | 0 | - | - | 0 | 0 |
Issued stock for commission and option expense | ||||||
0 | 0 | 0 | - | 0 | 0 | 0 |
Convertible note related accretion expense | ||||||
26 | 26 | 119 | 152 | 0 | 0 | 0 |
Changes in non-cash operating balances: | ||||||
Accounts receivable and other receivables | ||||||
-11 | -20 | -7 | -77 | 0 | 0 | 0 |
Prepaid expense | ||||||
-5 | -14 | -11 | 0 | 0 | 0 | 0 |
Inventories | ||||||
-18 | -34 | -13 | -13 | 0 | 0 | 0 |
Accounts payable and accrued liabilities | ||||||
-391 | 227 | 87 | 863 | 0 | 0 | 0 |
Net cash flows used in operating activities | ||||||
-7,383 | -7,440 | -7,299 | -6,206 | 0 | 0 | 0 |
Cash flows from financing activities | ||||||
Proceeds from issuance of share capital | ||||||
10,313 | 11,215 | 6,871 | 5,039 | 0 | 0 | 0 |
Warrants Exercise | ||||||
- | - | - | - | - | - | 0 |
Net cash flows provided by financing activities | ||||||
10,313 | 11,215 | 6,517 | 5,039 | 0 | 0 | 0 |
Cash flows used in investing activities | ||||||
Net (decrease) increase in cash | ||||||
2,919 | 3,775 | -782 | -1,167 | 0 | 0 | 0 |